Stefan K.F. Schwabe

2018

In 2018, Stefan K.F. Schwabe earned a total compensation of $1.3M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,000
Option Awards$695,815
Salary$389,500
Other$30,384
Total$1,278,699

Schwabe received $695.8K in option awards, accounting for 54% of the total pay in 2018.

Schwabe also received $163K in non-equity incentive plan, $389.5K in salary and $30.4K in other compensation.

Rankings

In 2018, Stefan K.F. Schwabe's compensation ranked 7,972nd out of 14,244 executives tracked by ExecPay. In other words, Schwabe earned more than 44.0% of executives.

ClassificationRankingPercentile
All
7,972
out of 14,244
44th
Division
Manufacturing
3,135
out of 5,762
46th
Major group
Chemicals And Allied Products
1,170
out of 2,125
45th
Industry group
Drugs
982
out of 1,814
46th
Industry
Pharmaceutical Preparations
762
out of 1,388
45th

Pay ratio

Stefan K.F. Schwabe's Pay$1,278,699
Median Employee's Pay$131,026
Pay Ratio

10

to 1

In 2018, the annual total compensation of Stefan K.F. Schwabe was $1,278,699.

The annual total compensation of the median employee at Supernus Pharmaceuticals was $131,026.

The ratio of Stefan K.F. Schwabe's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 29, 2019.

Schwabe's colleagues

We found five more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2018.

2018

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2018

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2018

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

2018

Victor Vaughn

Supernus Pharmaceuticals

Former Senior Vice President of Sales and Marketing

2018

Tami RN

Supernus Pharmaceuticals

Senior Vice President, Regulatory Affairs

News

In-depth

You may also like